Assessment Status | Rapid Review Complete |
HTA ID | 23003 |
Drug | Voclosporin |
Brand | Lupkynis® |
Indication | Voclosporin is indicated in combination with mycophenolate mofetil for the treatment of adult patients with active class III, IV or V (including mixed class III/V and IV/V) lupus nephritis (LN). |
Assessment Process | |
Rapid review commissioned | 10/01/2023 |
Rapid review completed | 10/02/2023 |
Rapid review outcome | A full HTA is recommended to assess the clinical effectiveness and cost effectiveness of voclosporin compared with the current standard of care. |